DHR - Danaher Corporation

NYSE - NYSE Delayed Price. Currency in USD
129.86
+1.79 (+1.40%)
At close: 4:03PM EDT
Stock chart is not supported by your current browser
Previous Close128.11
Open128.53
Bid127.61 x 1400
Ask132.42 x 1400
Day's Range128.39 - 129.94
52 Week Range94.59 - 129.94
Volume3,165,156
Avg. Volume3,175,206
Market Cap92.717B
Beta (3Y Monthly)0.93
PE Ratio (TTM)34.76
EPS (TTM)3.74
Earnings DateApr 18, 2019
Forward Dividend & Yield0.68 (0.53%)
Ex-Dividend Date2019-03-28
1y Target Est130.50
Trade prices are not sourced from all markets
  • PR Newswire13 hours ago

    Danaher Schedules First Quarter 2019 Earnings Conference Call

    WASHINGTON, March 19, 2019 /PRNewswire/ --Danaher Corporation (DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 1492175).

  • UTX vs. DHR: Which Stock Should Value Investors Buy Now?
    Zacks20 hours ago

    UTX vs. DHR: Which Stock Should Value Investors Buy Now?

    UTX vs. DHR: Which Stock Is the Better Value Option?

  • Danaher to Gain From Solid Demand in Key Markets Amid Risks
    Zacks2 days ago

    Danaher to Gain From Solid Demand in Key Markets Amid Risks

    Effective implementation of Danaher Business System and solid demand for innovative products are likely to boost Danaher's (DHR) revenues.

  • Markit8 days ago

    See what the IHS Markit Score report has to say about Danaher Corp.

    Danaher Corp NYSE:DHRView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for DHR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting DHR. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold DHR had net inflows of $4.17 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Industrials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. DHR credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Why General Electric Stock Plunged ~7% Last Week
    Market Realist9 days ago

    Why General Electric Stock Plunged ~7% Last Week

    Why General Electric Stock Plunged ~7% Last WeekGE stock fellGeneral Electric stock (GE) fell ~7% last week on growing concerns over its turnaround. The stock’s first major blow was on March 5 after the company’s CEO, Larry Culp, warned about

  • Too Early or Too Late? General Electric Stock Has Investors Guessing
    InvestorPlace9 days ago

    Too Early or Too Late? General Electric Stock Has Investors Guessing

    A reader asked me recently about General Electric (NYSE:GE) after a "financial professional" had put him into GE stock in a big way and hadn't gotten him out as it crashed and burned. With the shares hovering at around $9.50 a piece, what should he do?Source: Shutterstock My first reaction was to scream "sell!". Then it looked like new CEO Larry Culp had a handle on things, selling GE's biopharma assets to his former employer, Danaher (NYSE:DHR) for $21.4 billion. The stock rose back to more than $10 per share.Maybe, hold, I thought?InvestorPlace - Stock Market News, Stock Advice & Trading TipsNo. Culp said this week that GE Power will be burning cash for years and with that, GE stock fell back to its March 7 opening bid of $9.09. Too Late?If you ignored my repeated warnings over the last year to get out of GE stock , you have lost more than two-thirds of your investment since mid-2016, along with almost all of your dividend.GE, once a mainstay of the Dow Jones 30 Industrials and its last original member before getting the boot in June 2018, is now a shell of its former self. The reader's note infuriated me. How could a financial professional keep a client aboard this plane while it crashed? * 5 Airline Stocks In Serious Trouble Worrying about GE, predicting either its recovery or imminent demise, has become a cottage industry as John Flannery, then Larry Culp, struggled to come to grips with the value destruction wrought by Jeff Immelt.The problem is GE Power. Immelt bet the company on oil and gas just as renewable energy, especially efficiency, was taking off. Then came production problems. Too Early?Culp, who built Danaher into a cutting-edge technology conglomerate before taking early retirement at the Harvard Business School, a few miles from Immelt's new Boston headquarters, has a different plan.Instead of spinning out GE Health, as Flannery planned, Culp seems determined to keep it. Cutting-edge health technology was at the heart of his success at Danaher.Culp has even talked about restoring the dividend which, if it returned to its original level, 30 cents per share, would yield more than 10% at the stock's current price. If he could fix the cash flow problems at GE Power, the rest of the company -- aviation, health care, and renewable energy -- can succeed.Culp said all the right things and seemed to be doing the right things. Some analysts began coming around. Others counseled patience.Then came the news on industrial cash flow. Even with all its troubles, GE still generated $4.5 billion in industrial free cash flow last year. Now Culp says that will be negative in 2019. The Bottom Line on GE StockCulp seems like an honorable man. Flannery also seemed like an honorable man. Even Immelt, in his heyday, was considered an honorable man. They are all honorable men, yet the body of General Electric remains there, bleeding on the floor, as we approach the ides of March. * 7 Dow Jones Stocks to Buy Culp admits he can't fix GE Power this year, or even next year. It will continue to drag down results. Meanwhile the company's debt, which now amounts to more than 3.5 times its equity, must be paid, with $26 billion maturing in the next few years. Culp is now thinking of selling part of the renewables business.There are analysts who, even today, pound the table for GE stock. These people are fools.You may get a better price for General Electric stock tomorrow or the next day. Stock prices are volatile. But it won't be much higher, not for years, not until Culp can see the light at the end of the current dark tunnel.Until then your money should be doing something else.Dana Blankenhorn is a financial and technology journalist. He is the author of a new mystery thriller, The Reluctant Detective Finds Her Family, available now at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. As of this writing he owned no shares in companies mentioned in this article. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Dividend Stocks Already Rewarding Shareholders In 2019 * The 10 Best-Performing ETFs This Year * 7 Stocks That Should Be Worried About a Data Dividend Compare Brokers The post Too Early or Too Late? General Electric Stock Has Investors Guessing appeared first on InvestorPlace.

  • PR Newswire11 days ago

    Danaher Announces Quarterly Dividend

    WASHINGTON , March 8, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share payable on April ...

  • What the GE-Danaher Deal Means to Both Sets of Investors
    Motley Fool12 days ago

    What the GE-Danaher Deal Means to Both Sets of Investors

    It's ultimately good news for both companies. Here's why.

  • GE Fell ~8% after J.P. Morgan Warned of More Downside Risk
    Market Realist13 days ago

    GE Fell ~8% after J.P. Morgan Warned of More Downside Risk

    GE Fell ~8% after J.P. Morgan Warned of More Downside RiskJ.P. Morgan sees more downsideGeneral Electric (GE) stock extended its declines for the second consecutive day after JPMorgan Chase’s (JPM) well-renowned analyst Stephen Tusa warned of more

  • The Wall Street Journal13 days ago

    [$$] The Investors Who Bet Big on GE

    For the newest investors in General Electric Co., the proof is in the $21 billion biotechnology deal. The conglomerate’s agreement last week to sell that small but fast-growing business to Danaher Corp. provided a moment of validation to a group of value-seeking stock buyers who plowed into the stock at the end of 2018 amid fears the company was collapsing. In the fourth quarter, investors who seek undervalued or misunderstood stocks turned toward GE for the first time in years, buying some $4 billion in aggregate, according to S&P Global Market Intelligence and using average prices from the period.

  • Has the Turnaround of  GE Stock Already Come and Gone?
    InvestorPlace14 days ago

    Has the Turnaround of GE Stock Already Come and Gone?

    For the past several years, industrial conglomerate General Electric (NYSE:GE) has been on a continuous downtrend. Once one of the most important, valuable, and influential companies in the world, GE has turned into a shell of its former self thanks to mismanagement, an unbearable debt load, and a lack of company-wide innovation. This has led to GE stock turning into one of Wall Street's biggest losers for the past several years.Source: Shutterstock But GE stock has surprisingly turned into a big winner in early 2019. Year-to-date, General Electric stock is up 30%, as the technicals, fundamentals, and sentiment of GE stock have all meaningfully improved in 2019. Can this rally last? Is this the beginning of a multi-year rebound by GE stock? Or has the rally already come and gone? * 9 Trade War Stocks to Sell on U.S.-China Deal News That's tough to say. GE is making all the right moves to downsize and simplify its operations. Consequently, the GE of tomorrow will have stable, healthy growth with dramatically lower leverage and significantly higher margins.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut the GE of tomorrow will also be much smaller and potentially have even less growth potential. Indeed, although GE is downsizing its operations and cutting its operational fat, CEO Larry Culp recently said that he expects its industrial-free-cash flow to be negative in 2019.In other words, things are getting better at GE, but not that much better. As a result, after GE stock rallied over the past few months, the risk-reward profile of General Electric stock at this point in time seems neither favorable nor unfavorable. It simply seems balanced. Balanced isn't a good enough reason to buy this stock, considering the lack of clarity of the company's long-term outlook and the recent rally of GE stock. As a result, I think investors should wait before buying into the rally of GE. All the Right MovesGE's management and GE stock are making all the right moves, and that's why GE stock is up 30% in 2019.Importantly, GE stock held the critical technical level of $6.66, which was the stock's long-term level of support that dates all the way back to 2009. Not only did GE stock hold that level, but it bounced off that level in a big way. Indeed, ever since, General Electric stock is up about 40%. That's a big move which implies that GE stock has indeed put in a bottom.More importantly, GE's management is doing everything right as it looks to reduce the company's leverage and improve its operational stability and profitability. Namely, the company is shedding assets rapidly.Among the assets that GE has sold are its transportation unit {to Wabtec (NYSE:WAB),} its biopharma business {to Danaher (NYSE:DHR),} and its Intelligent Platforms business {to Emerson (NYSE:EMR)}. Taken together, these downsizing moves have simplified the company's operations, improved its long-term profitability outlook, brought cash onto its balance sheet, and reduced its leverage.In other words, things look good for GE stock. Everything that needed to happen is happening. The stock held its long-term level of support. Assets are being sold. Leverage is being reduced. Operations are being simplified.As long as the company's management continues to make these type of strategic and value-adding moves, it's tough to see General Electric stock falling. But it's equally hard to see GE stock resuming its rapid run higher. Balanced Risk-RewardThe biggest concern about GE stock is that the company is "selling its future to try and maintain the present", as J.P. Morgan's Stephen Tusa pointed out in a recent note.Tusa was referring to the company's decision to sell the more valuable assets of its Aviation Services business. But the statement has broader applications. GE is selling a ton of assets. Many of those assets aren't half-bad. Some are even good, like GE Healthcare.To be sure, spinning off those businesses does provide a large amount of cash inflows, which are necessary to reduce the company's unsustainable debt load. But, while debt reduction is an admirable goal, investors should ask: what's next? What happens after the debt load is reduced, but many of the businesses are gone? Will General Electric stock have a bright future at that point?No one knows the answers to those questions right now. The only tangible insight we do have is that the company's industrial-free-cash-flow is expected to be negative this year, and that isn't good news.So given the enormous lack of clarity regarding what exactly will be left of GE in two to three years and the recent negative news, it's tough to see GE stock rallying in the foreseeable future. The Bottom Line on GE StockThe big rebound of General Electric stock has already happened. The next leg higher will have to be driven by improvements in its fundamental growth outlook. Such improvements can only come via increased clarity with respect to what GE will look like in two to three years. Until GE's long-term outlook is clearer, GE stock will struggle to stay on its winning trajectory.As of this writing, Luke Lango did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Blue-Chip Stocks That Will Lose You Money * 7 Cheap Stocks Under $5 That Could Soar * 7 Stocks Under $10 You Shouldn't Buy Compare Brokers The post Has the Turnaround of GE Stock Already Come and Gone? appeared first on InvestorPlace.

  • MarketWatch14 days ago

    GE's stock tumbles again after downbeat cash flow outlook and analyst call

    Shares of General Electric Co. tumbled 6.8% in premarket trade Wednesday, to extend the previous session's 4.7% selloff following a downbeat cash flow outlook for the year. The stock is on track to erase all of the gains, and then some, on the back of the announcement last week that it was selling its biopharma business to Danaher Corp. for $21.4 billion in cash. "We disagree with the view that it's 'not that bad,' and while 'cutting numbers, reiterating buy' is fairly common from the sell side, we reject this approach of cut and push to next year," which has been going on for a very long time for some, wrote analyst Stephen Tusa at J.P. Morgan. "As long as this sentiment prevails, we don't think the stock can bottom." He reiterated his neutral rating and stock price target of $6, which is 39% below Tuesday's closing price, but Tusa said is starting to look "generous." CFRA analyst Jim Corridore said while he's not surprised by the negative cash flow outlook for this year, given the troubles at GE's power division, he's keeping his rating at buy as he believes the company is moving in the right direction. The stock has plunged 29.7% over the past 12 months, while the Dow Jones Industrial Average has gained 3.7%.

  • GlobeNewswire14 days ago

    Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics — Future Expectations, Projections Moving into 2019

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.

  • How Corporate America's New Debt Diet Will Boost Stocks
    Investopedia15 days ago

    How Corporate America's New Debt Diet Will Boost Stocks

    Several major U.S. companies are reducing their large debt loads, in a move that may be good for stock and bond prices alike.

  • ETF Trends16 days ago

    Healthcare ETF Keeps Hitting New Highs

    Just a dozen ETFs hit record highs on Friday. Extending its 2019 gains to 15%, the iShares US Medical Devices ETF (NYSEArca: IHI) was one of the ETFs hitting all-times on Friday. That as the broader healthcare ...

  • Barrons.com16 days ago

    GE Stock Could Almost Double to $20, Says Analyst

    Several analysts have updated their assumptions about GE’s debt and earnings following the sale of its biopharmaceuticals business last week.

  • Will Danaher Corporation’s (NYSE:DHR) Earnings Grow In The Next 12 Months?
    Simply Wall St.16 days ago

    Will Danaher Corporation’s (NYSE:DHR) Earnings Grow In The Next 12 Months?

    As Danaher Corporation (NYSE:DHR) released its earnings announcement on 31 December 2018, it seems that analyst forecasts are fairly optimistic, with profits predicted to increase by 7.2% next year comparedRead More...

  • Danaher's Stock Offering Proceeds to Fund BioPharma Buyout
    Zacks16 days ago

    Danaher's Stock Offering Proceeds to Fund BioPharma Buyout

    Danaher (DHR) successfully completes the offering of common and preferred shares. It intends on using the funds raised to pay for the pending acquisition of General Electric's BioPharma business.

  • PR Newswire18 days ago

    Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

    WASHINGTON, March 1, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The amounts sold include 1,100,000 shares of common stock and 150,000 shares of Mandatory Convertible Preferred Stock issued pursuant to the exercise in full of the separate options granted to the underwriters in each of the respective offerings to purchase additional shares.

  • Bloomberg18 days ago

    GE Nuggets to Chew on From Its Annual Report

    Also of note, GE specifically called out an economic slowdown in China among the risk factors for its business, a change from the previous year. GE also flagged increased costs in its health-care business due to U.S. tariffs on equipment and components imported from China and said it’s working to mitigate that by moving operations elsewhere. In November, current CEO Larry Culp kickstarted the unwinding of the company’s stake in the merger of its energy assets with Baker Hughes, selling a chunk of stock at what was at the time the lowest stock price since the deal was completed.

  • MarketWatch20 days ago

    GE's stock sinks to pace industrial sector's losers; set to snap 4-day win streak

    General Electric Co.'s stock sank 4.2% in midday trade Thursday, enough to pace the decliners in the SPDR Industrial Select Sector ETF , after running up 13% the past four sessions. UBS analyst Peter Lennox-King reiterated his buy rating and $13 stock price target, which is 23% above current levels. He said his initial impressions from GE's 10-K filing were than there didn't appear to be any "red flags," as the company provided more clarity into GE's operations and financials, but he acknowledged that "mortality/morbidity remain risks." GE's stock had gotten a big boost earlier this week by the deal to sell its biopharma business to Danaher Corp. for $21.4 billion. The stock's Wednesday closing price of $10.88 was fractionally below the 200-day moving average of $10.8838, according to FactSet, to extend the longest streak below that widely watched technical threshold--529 sessions--in at least 40 years. The stock has still run up 43% year to date, while the industrial ETF has rallied 19% and the Dow Jones Industrial Average has gained 11%.

  • Is Larry Culp Leading General Electric In the Right Direction?
    InvestorPlace20 days ago

    Is Larry Culp Leading General Electric In the Right Direction?

    He certainly said all the right things, and, he said them in the right way … Now, just because General Electric (NYSE:GE) CEO Larry Culp can make investors feel good, it doesn't necessarily mean Culp can produce results that will drive GE stock higher.Source: Shutterstock Boiled down to its most basic form, that's the crux of the debate surrounding General Electric stock right now, following Tuesday's release of Larry Culp's first letter to owners of General Electric stock.The message was long on ideas and goals. Yet, it was short on specifics regarding how he may actually be able to lead GE out of perdition and back to its former greatness.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * Want 7%+ Yields and Growth? The market is patient with the company right now, but that won't be a permanent condition. The Math Is the MathIt was, by and large, a typical letter to shareholders, cheering the good, acknowledging the not-so-good, and painting a picture of a bright future that will focus more on the customer and improving the balance sheet.It also means little in the grand scheme of things, as most CEO missives to the market do.That doesn't mean investors didn't respond. They loved it, and had they not propelled GE stock up to the tune of 10% on Monday following news it was selling its biopharma unit to Danaher (NYSE:DHR), they may have been willing to pour in again in a big way. Still, up more than 50% from its December low, clearly the crowd believes in GE again.Not the whole crowd though.J.P. Morgan analyst Stephen Tusa is no stranger to being in the minority. Good thing too. His price target of $6.00 for GE stock is not only well below the stock's current price near $10.70, it's also the lowest target sported by Wall Street's pros.And yet, Tusa's view of General Electric may be the most sound, and least swayed by hollow hope."At this stage of the game, the math is the math," says Tusa, who believed GE's free cash flow for the current year will be in the range of $1.5 billion to $2.0 billion. Tusa goes on to explain, however, "I can tell you right now, that $10 per share does not reflect where fundamentals currently stand.""They are giving a massive amount of benefit to a significant swing in Power, from negative $3.0 billion in free cash to probably about $1.0 billion(+) in free cash over the next three years," continues Tusa, who adds "and they are also assuming that GE Capital is zero [in free cash flow]" when the company's capital arm is still bleeding cash."Tusa doesn't think the company's Power arm will flip to profitability that quickly. He also points out "GE Capital is not a zero [in terms of cash burn]. GE Capital is a substantial negative … [with] significant drags over the next couple of years." Missed OpportunityWhile not intended to be a shot against Culp or his plan (Tusa likes and respects Culp), the analyst's response did resonate with more than a handful of investors that re-read Culp's letter. The goals were compelling.They just weren't accompanied by a plausible plan to meet them. What does "We are investing in high-tech industries where we have large, mission-critical installed bases with high potential for aftermarket services and parts" mean, exactly?It's not a damning indictment of the company or GE stock. A letter from a CEO to shareholders isn't the proper forum to lay out specifics about a plan of action anyway. Those matters are generally dished out in pieces, as they become relevant. They're also often concealed to prevent competitors from disrupting those plans.General Electric isn't an Apple (NASDAQ:AAPL) or an Nvidia (NASDAQ:NVDA) though, which would benefit from such top-secret initiatives. GE is an open book. The market knows it's got too much debt, not enough cash flow, and too many lingering liabilities with its Capital arm. Its Renewable Energy division holds promise, but its growth outlook is best measured in years, if not decades. Its Aviation arm is impressive, but that's a crowded field.If there was ever a time to talk about specifics beyond 'fewer, more impactful priorities,' Culp's letter to investors would have been it. Reality Check for GE Stock HoldersOr, perhaps the lack of details is a subtle hint of something else … that there are no details to speak of. It's a premise that typically doesn't fly on neither Wall Street nor Main Street. Investors love certainty and abhor ambiguity.When it comes to GE, however, there is no elegant grand plan investors can readily latch onto.The only plan to speak of right now is selling assets until its debt bomb has been defused, and to hang on for dear life while it figures out how to collect more in revenue than it spends. There's nothing elegant about bailing water out of a boat. Speed is the key; the patch job tends to be ugly.Nevertheless, Larry Culp is still one of the most qualified -- if not the most qualified -- to lead that bailing and patching before GE sinks to the bottom of the ocean. If nothing else, his calmness and coolness provide a glimmer of hope.Let's see if the market is as optimistic about Culp a year from now, when the company has to start improving cash flow with its remaining pieces. By that point, GE stock owners should start demanding the product-based and service-based specifics that are missing thus far. If they don't get them then …As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 5 STARS Stocks That Continue to Define the Future * 7 of the Best ETFs to Buy for a Rock-Solid Portfolio * 5 Real Estate Stocks to Buy for Dividend Income Compare Brokers The post Is Larry Culp Leading General Electric In the Right Direction? appeared first on InvestorPlace.

  • GE Intends to Lower Debt Burden, Boost Dividend Payments
    Zacks20 days ago

    GE Intends to Lower Debt Burden, Boost Dividend Payments

    General Electric (GE) seeks to become more competent on the back of its initiatives to improve financial position and strengthen core businesses.

  • GE Soared after Larry Culp Stresses Debt Cut and Dividend Boost
    Market Realist21 days ago

    GE Soared after Larry Culp Stresses Debt Cut and Dividend Boost

    GE Soars after Larry Culp Stresses Debt Cut and Dividend BoostCEO tries to reassure shareholdersGeneral Electric (GE) was trading 1.4% higher in pre-market trading today after CEO Larry Culp reassured investors the company would return to a

  • TheStreet.com21 days ago

    General Electric Biopharma Sale Helps Debt Reduction, Hurts Earnings - JPM Tusa

    move to sell the biopharma portion of its healthcare business to Danaher Corp. likely gives the company and extra $3.5 billion it can use to reduce its balance sheet, but will also cut into overall earnings in an already weakened company, according to one of Wall Street's top analysts. JPMorgan's Stephen Tusa, one of the most influential analysts on Wall Street and long-time critic of GE's flagging business model, said that while the $20.5 billion in cash it will get from Danaher was more than many had expected, it still leaves GE Heathcare as an asset that is "short on growth, with an implied total EV that is below" based Tusa's recent analysis, with around $17 billion in annual revenues and operating margins "in the mid-teens".